JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiedmer, T.
Right arrow Articles by Sims, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiedmer, T.
Right arrow Articles by Sims, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 261, Issue 31, 14587-14592, Nov, 1986

On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity

T Wiedmer, CT Esmon and PJ Sims

Membrane assembly of complement proteins C5b-9 on human platelets results in a dose-dependent increase in the binding of coagulation factors Va and Xa to the plasma membrane, concomitant with a marked increase in platelet prothrombinase activity. Factor Va binding increased by 6-15-fold in platelets treated with the C5b-9 proteins as compared to controls. In the presence of near-saturating concentrations of factor Xa, factor Va binding to C5b-9-treated platelets approximately doubled. In the absence of added factor Va, C5b-9-treated platelets bound 1700 molecules of factor Xa versus 50 molecules/cell bound to controls, suggesting that C5b-9 assembly on the platelet surface initiates the release of platelet factor V from the alpha- granules. The capacity of the C5b-9 proteins to initiate the nonlytic release of the platelet alpha-granule storage pool was confirmed by assay for platelet factor 4. When measured in the presence of exogenous factor Va (2 micrograms/ml), factor Xa uptake by C5b-9 platelets increased to approximately 5500 molecules/cell (versus 330 molecules/cell for controls). Removal of external Ca2+ inhibited the C5b-9-initiated release of the alpha-granule storage pool and reduced by approximately 50% the expression of new factor Va binding sites, suggesting that these two events contributing to increased platelet prothrombinase activity are mediated in part by the influx of Ca2+ across the C5b-9 pore.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
I. del Conde, M. A. Cruz, H. Zhang, J. A. Lopez, and V. Afshar-Kharghan
Platelet activation leads to activation and propagation of the complement system
J. Exp. Med., March 21, 2005; 201(6): 871 - 879.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. F. Mojcik and J. H. Levy
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
Ann. Thorac. Surg., February 1, 2001; 71(2): 745 - 754.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. S. Rinder, H. M. Rinder, M. J. Smith, J. B. Tracey, J. Fitch, L. Li, S. A. Rollins, and B. R. Smith
SELECTIVE BLOCKADE OF MEMBRANE ATTACK COMPLEX FORMATION DURING SIMULATED EXTRACORPOREAL CIRCULATION INHIBITS PLATELET BUT NOT LEUKOCYTE ACTIVATION
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 460 - 466.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Sawada, H. Yanamoto, I. Nagata, N. Hashimoto, I. Nakahara, Y. Akiyama, H. Kikuchi, and R. L. Macdonald
Prevention of Neointimal Formation by a Serine Protease Inhibitor, FUT-175, After Carotid Balloon Injury in Rats • Editorial Comment
Stroke, March 1, 1999; 30(3): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. M. Jansen, B. Eisele, I. W. de Jong, A. Chang, U. Delvos, F. B. Taylor Jr., and C. E. Hack
Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock
J. Immunol., January 1, 1998; 160(1): 475 - 484.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.